# Kyverna Therapeutics, Inc.: filings

KYTX · Nasdaq · CIK 1994702 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kytx.md) · [Financials](/companies/kytx/financials.md) · [Filings](/companies/kytx/filings.md) · [Insiders](/companies/kytx/insiders.md)

## Reports and events: 58 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 41, 4 40, 3 26, 10-Q 8, UPLOAD 7, CORRESP 6, 144 5, 424B5 4, S-8 4, SCHEDULE 13G/A 4, 10-K 3, DRS/A 3, DRSLTR 3, EFFECT 3, SC 13G 3, ARS 2, DEF 14A 2, DEFA14A 2, S-1/A 2, S-3 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, FWP 1, S-1 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 10:00 ET | [8-K](/filings/0001193125-26-400062.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-400062 |
| 2026-08-11 | 20:07 ET | [10-Q](/filings/0001193125-26-344607.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344607 |
| 2026-08-11 | 20:04 ET | [8-K](/filings/0001193125-26-344572.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344572 |
| 2026-07-27 | 12:00 ET | [8-K](/filings/0001193125-26-316916.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-316916 |
| 2026-07-09 | 10:00 ET | [8-K](/filings/0001193125-26-298979.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-298979 |
| 2026-06-02 | 20:30 ET | [8-K](/filings/0001193125-26-253604.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-253604 |
| 2026-05-18 | 12:00 ET | [8-K](/filings/0001193125-26-227920.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-227920 |
| 2026-05-12 | 20:08 ET | [10-Q](/filings/0001193125-26-219397.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219397 |
| 2026-05-12 | 20:05 ET | [8-K](/filings/0001193125-26-219377.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219377 |
| 2026-05-04 | 12:00 ET | [8-K](/filings/0001193125-26-202610.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202610 |
| 2026-04-22 | 11:00 ET | [8-K](/filings/0001193125-26-168287.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-168287 |
| 2026-04-22 | 22:45 ET | [8-K](/filings/0001193125-26-167512.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-167512 |
| 2026-04-20 | 12:00 ET | [8-K](/filings/0001193125-26-162755.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-162755 |
| 2026-04-13 | 20:02 ET | [DEF 14A](/filings/0001193125-26-152835.md) | Proxy statement, period 2026-05-27 | 0001193125-26-152835 |
| 2026-03-26 | 20:11 ET | [10-K](/filings/0001193125-26-126242.md) | Annual report, period 2025-12-31 | 0001193125-26-126242 |
| 2026-03-26 | 20:06 ET | [8-K](/filings/0001193125-26-126216.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126216 |
| 2026-02-24 | 13:00 ET | [8-K](/filings/0001193125-26-065320.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-065320 |
| 2026-02-03 | 13:00 ET | [8-K](/filings/0001193125-26-034464.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-034464 |
| 2026-01-12 | 13:00 ET | [8-K](/filings/0001193125-26-009810.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-009810 |
| 2025-12-18 | 02:50 ET | [8-K](/filings/0001213900-25-123033.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-123033 |
| 2025-12-15 | 13:00 ET | [8-K](/filings/0001193125-25-318469.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-318469 |
| 2025-12-15 | 11:30 ET | [8-K](/filings/0001193125-25-318377.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-318377 |
| 2025-11-12 | 21:11 ET | [10-Q](/filings/0001193125-25-277584.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277584 |
| 2025-11-12 | 21:09 ET | [8-K](/filings/0001193125-25-277569.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277569 |
| 2025-11-03 | 13:00 ET | [8-K](/filings/0001193125-25-261719.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-261719 |
| 2025-10-29 | 12:00 ET | [8-K](/filings/0001193125-25-254698.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-254698 |
| 2025-10-29 | 10:32 ET | [8-K](/filings/0001193125-25-254571.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-254571 |
| 2025-09-25 | 20:05 ET | [8-K](/filings/0001193125-25-217434.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-217434 |
| 2025-08-12 | 20:11 ET | [10-Q](/filings/0000950170-25-107321.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107321 |
| 2025-08-12 | 20:06 ET | [8-K](/filings/0000950170-25-107300.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107300 |
| 2025-06-30 | 13:01 ET | [8-K](/filings/0001213900-25-059289.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059289 |
| 2025-06-03 | 20:03 ET | [8-K](/filings/0000950170-25-080896.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-080896 |
| 2025-05-13 | 20:08 ET | [10-Q](/filings/0000950170-25-070325.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070325 |
| 2025-05-13 | 20:03 ET | [8-K](/filings/0000950170-25-070286.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070286 |
| 2025-04-14 | 20:03 ET | [DEF 14A](/filings/0000950170-25-053699.md) | Proxy statement, period 2025-05-29 | 0000950170-25-053699 |
| 2025-03-27 | 20:58 ET | [8-K](/filings/0000950170-25-046176.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-046176 |
| 2025-03-27 | 20:12 ET | [10-K](/filings/0000950170-25-046074.md) | Annual report, period 2024-12-31 | 0000950170-25-046074 |
| 2025-03-27 | 20:05 ET | [8-K](/filings/0000950170-25-046052.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046052 |
| 2025-01-21 | 21:06 ET | [8-K](/filings/0000950170-25-007220.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-007220 |
| 2025-01-13 | 12:35 ET | [8-K](/filings/0001213900-25-002831.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-002831 |
| 2024-11-26 | 21:40 ET | [8-K](/filings/0000950170-24-131074.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-131074 |
| 2024-11-13 | 21:24 ET | [10-Q](/filings/0000950170-24-126366.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126366 |
| 2024-11-13 | 21:16 ET | [8-K](/filings/0000950170-24-126342.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-126342 |
| 2024-10-21 | 12:00 ET | [8-K](/filings/0001213900-24-089095.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-089095 |
| 2024-09-16 | 12:05 ET | [8-K](/filings/0001213900-24-078736.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-078736 |
| 2024-08-12 | 20:18 ET | [10-Q](/filings/0000950170-24-095462.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095462 |
| 2024-08-12 | 20:11 ET | [8-K](/filings/0000950170-24-095433.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095433 |
| 2024-07-15 | 20:11 ET | [8-K](/filings/0000950170-24-083570.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-083570 |
| 2024-06-14 | 10:12 ET | [8-K](/filings/0000950170-24-073312.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-073312 |
| 2024-05-14 | 20:29 ET | [10-Q](/filings/0000950170-24-059628.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059628 |

Page 1 of 2. [Older](/companies/kytx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.